StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / ochre-bio.com

Ochre Bio

Ochre Bio (ochre-bio.com): 6 changes recorded in its website history since March 2020. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeGSK signs AI pact with Ochre to pinpoint source of liver diseases
    AfterHuman data. Human models. Human translation.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. InvestorsBetween and

    Now shows investor logos: GSK-, khosla ventures, backedvclogo, Alexandria_Real_Estate_Equities_logo, ApolloVC_LogoUpdate, lifelinkventures and hermes epitek.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. HeadlineBetween and
    BeforeOxford biotech raises funds to make RNA treatments for liver disease
    AfterGSK signs AI pact with Ochre to pinpoint source of liver diseases

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  4. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  5. HeadlineBetween and
    BeforePhenomics-led RNA medicines
    AfterOxford biotech raises funds to make RNA treatments for liver disease

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  6. MessagingBetween and
    Beforegenomic medicines
    AfterPhenomics-led RNA medicines

    Classifier interpretation of website text.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 18 March 2020

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

genomic medicines

Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. January 2026 – November 2026 · 3 captures · latest observed messagingHuman data. Human models. Human translation.

    Ochre Bio is developing therapies for the biggest liver health challenges.

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 3 captures in this group
    • 7 January 2026 · Human data. Human models. Human translation. archived page
    • 31 July 2026 · Human data. Human models. Human translation. archived page
    • 6 November 2026 · Human data. Human models. Human translation. current websiteHistorical capture not publicly available
  2. July 2024 – January 2025 · 2 capturesGSK signs AI pact with Ochre to pinpoint source of liver diseases

    Ochre Bio is developing therapies for the biggest liver health challenges.

    This wording observed 9 January 2025.

    archived page
    Inspect 2 captures in this group
    • 13 July 2024 · GSK signs AI pact with Ochre to pinpoint source of liver diseases archived page
    • 9 January 2025 · GSK signs AI pact with Ochre to pinpoint source of liver diseases archived page
  3. January 2023 – September 2023 · 2 capturesOxford biotech raises funds to make RNA treatments for liver disease

    Ochre Bio is developing therapies for the biggest liver health challenges.

    This wording observed 26 September 2023.

    archived page
    Inspect 2 captures in this group
    • 20 January 2023 · Oxford biotech raises funds to make RNA treatments for liver disease archived page
    • 26 September 2023 · Oxford biotech raises funds to make RNA treatments for liver disease archived page
  4. March 2020 – January 2022 · 4 capturesPhenomics-led RNA medicines

    Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.

    This wording observed 3 January 2022.

    archived page
    Inspect 4 captures in this group
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Ochre Bio updates homepage messaging and shows investor logos

Ochre Bio has revised its homepage headlines multiple times, added a careers page, and now displays several investor logos.

  • Reading: Between November 2020 and July 2021, a classifier read Ochre Bio’s homepage change from “genomic medicines” to “Phenomics-led RNA medicines” as a repositioning. [1]
  • Between January 2022 and January 2023, Ochre Bio changed its homepage headline to “Oxford biotech raises funds to make RNA treatments for liver disease”. [2]
  • Between January 2022 and January 2023, Ochre Bio added a careers page. [3]
  • Between July 2024 and January 2025, Ochre Bio began showing investor logos: GSK-, khosla ventures, backedvclogo, Alexandria_Real_Estate_Equities_logo, ApolloVC_LogoUpdate, lifelinkventures and hermes epitek. [5]

Cite this record

StartupHistory, “Ochre Bio” company record, https://startuphistory.org/c/ochre-bio.com

Machine-readable: /c/ochre-bio.com.json. How changes are found: method.